DuPont Announces Agreement to Divest Aramids Business to Arclin
DuPont (NYSE: DD) has announced the sale of its Aramids business (Kevlar® and Nomex®) to Arclin for $1.8 billion. The transaction structure includes $1.2 billion in cash, a $300 million note receivable, and a 17.5% equity stake valued at $325 million in the future Arclin company.
The Aramids business, which generated net sales of $1.3 billion in 2024, includes approximately 1,900 employees and five manufacturing sites. The deal is expected to close in Q1 2026, subject to regulatory approval. This divestiture will not affect DuPont's planned separation of its electronics business (Qnity), scheduled for November 1, 2025.
DuPont (NYSE: DD) ha annunciato la cessione della sua divisione Aramidi (Kevlar® e Nomex®) ad Arclin per 1,8 miliardi di dollari. La struttura dell'operazione prevede 1,2 miliardi di dollari in contanti, un pagherò da 300 milioni e una partecipazione azionaria del 17,5% valutata 325 milioni di dollari nella futura società Arclin.
La divisione Aramidi, che ha registrato vendite nette per 1,3 miliardi di dollari nel 2024, comprende circa 1.900 dipendenti e cinque siti produttivi. Il closing è previsto per il primo trimestre del 2026, subordinato all'approvazione delle autorità regolatorie. Questa dismissione non influirà sulla prevista separazione del business electronics (Qnity) di DuPont, programmata per il 1° novembre 2025.
DuPont (NYSE: DD) ha anunciado la venta de su negocio de aramidas (Kevlar® y Nomex®) a Arclin por 1.800 millones de dólares. La transacción incluye 1.200 millones de dólares en efectivo, un Pagaré de 300 millones y una participación accionaria del 17,5% valorada en 325 millones de dólares en la futura compañía Arclin.
El negocio de aramidas, que registró ventas netas de 1.300 millones de dólares en 2024, cuenta con aproximadamente 1.900 empleados y cinco plantas de fabricación. El cierre está previsto para el primer trimestre de 2026, sujeto a la aprobación regulatoria. Esta desinversión no afectará la separación planeada del negocio de electrónica (Qnity) de DuPont, programada para el 1 de noviembre de 2025.
DuPont (NYSE: DD)갶 아라미드 사업부(Kevlar® � Nomex®)� 아크�(Arclin)� 18� 달러� 매각했다� 발표했습니다. 거래 구조� 12� 달러 현금, 3� 달러 약속어음, 향후 아크� 회사에서 갶치를 3� 2,500� 달러� 평갶받� 지� 17.5%� 구성됩니�.
아라미드 사업부� 2024� 순매� 13� 달러� 기록했으�, � 1,900명의 직원� 5개의 제조 시설� 보유하고 있습니다. � 거래� 규제 승인 조건 하에 2026� 1분기� 마무리될 예정입니�. 이번 매각은 DuPont� 전자사업(Qnity) 분할 계획(2025� 11� 1� 예정)� 영향� 미치지 않습니다.
DuPont (NYSE: DD) a annoncé la cession de son activité Aramides (Kevlar® et Nomex®) à Arclin pour 1,8 milliard de dollars. La structure de l'opération comprend 1,2 milliard de dollars en numéraire, un billet à recevoir de 300 millions et une participation de 17,5% évaluée à 325 millions de dollars dans la future société Arclin.
L'activité Aramides, qui a généré des ventes nettes de 1,3 milliard de dollars en 2024, comprend environ 1 900 employés et cinq sites de production. La clôture est attendue au 1er trimestre 2026, sous réserve des autorisations réglementaires. Cette cession n'affectera pas la séparation prévue de l'activité électronique (Qnity) de DuPont, programmée au 1er novembre 2025.
DuPont (NYSE: DD) hat den Verkauf seines -ұäڳٲ (Kevlar® und Nomex®) an Arclin für 1,8 Milliarden US-Dollar angekündigt. Die Transaktionsstruktur umfasst 1,2 Milliarden US-Dollar in bar, eine 300-Millionen-Dollar-Forderung und eine 17,5%-Beteiligung, die in der künftigen Arclin-Gesellschaft mit 325 Millionen US-Dollar bewertet wird.
Das Aramid-Geschäft, das Nettoerlöse von 1,3 Milliarden US-Dollar im Jahr 2024 erzielte, umfasst rund 1.900 Mitarbeiter und fünf Produktionsstandorte. Der Abschluss wird, vorbehaltlich behördlicher Genehmigungen, für das 1. Quartal 2026 erwartet. Diese Veräußerung wird die geplante Abspaltung des Elektronikgeschäfts (Qnity) von DuPont, terminiert auf den 1. November 2025, nicht beeinflussen.
- Transaction value of $1.8 billion represents significant monetization of assets
- DuPont retains 17.5% equity stake allowing participation in future growth
- Deal improves DuPont's growth and margin profile
- Aramids business demonstrated strong performance with $1.3 billion in sales (2024)
- Transaction provides significant cash proceeds for value creation initiatives
- Loss of revenue stream from profitable Aramids business
- Reduction in operational scale with divestment of 1,900 employees
- Transaction subject to regulatory approval, creating closing uncertainty
Insights
DuPont's $1.8B Aramids divestiture strengthens financial profile while maintaining upside potential through strategic equity retention.
DuPont's agreement to divest its Aramids business to Arclin represents a significant portfolio optimization with a transaction valued at
This transaction structure accomplishes two key objectives: it provides substantial immediate liquidity while maintaining participation in the future growth potential of the combined entity. The Aramids business, generating
From a portfolio management perspective, this divestiture aligns with DuPont's strategic transformation. By shedding a non-core asset while retaining partial ownership, management is executing a capital allocation strategy that improves the company's financial profile without completely sacrificing exposure to the Aramids business segment.
This transaction follows the broader industry trend of chemical companies streamlining portfolios to focus on higher-growth, higher-margin businesses. The deal structure demonstrates financial sophistication by balancing immediate value realization with long-term optionality. Importantly, the announcement confirms that this divestiture won't affect DuPont's planned electronics business separation (Qnity), which remains scheduled for November 1, 2025.
- Transaction structure maximizes shareholder value, enables participation in future upside potential of combined new entity
- Divestiture further streamlines the new DuPont portfolio and improves its financial profile
Arclin has received fully committed financing in connection with the transaction, which is expected to close in the first quarter of 2026, subject to customary closing conditions and regulatory approval.
At close, DuPont will receive pre-tax cash proceeds of approximately
"Today's announcement is another important step in our continued optimization of the new DuPont portfolio,"said Lori Koch, DuPont Chief Executive Officer. "The Aramids transaction further enhances the strategic focus of our portfolio, while also increasing the growth and margin profile. The transaction is structured to maximize value for our shareholders by providing significant cash proceeds at close which will be re-deployed to further drive value creation, while also allowing DuPont shareholders to participate in Arclin's growth potential through our retained equity interest," continued Koch.
"We are excited to partner again with TJC given their successful track record of creating value through an operations-focused approach and are confident in their ability to drive growth and opportunity for the employees and customers of the combined businesses," Koch concluded.
"The addition of Kevlar®and Nomex®to the Arclin portfolio presents a unique opportunity to transform our business with increased scale, broader global reach, and market-leading application development capabilities. The growth potential this acquisition presents will allow us to double down on our commitment to bringing impactful solutions and products to market, such as Arclin Firepoint, that protect what matters most,"said Bradley Bolduc, Arclin's President and Chief Executive Officer. "We are excited about the endless opportunities ahead of us with these businesses in our portfolio."
The Aramids business is the inventor and largest global producer of industry-leading high performance synthetic fibers that protect people, equipment and structures in high cost-of-failure applications. Aramids' synthetic fibers, Kevlar® and Nomex®, are well-known brands globally with a longstanding reputation for quality, product performance and supply reliability. With about 1,900 employees and five manufacturing sites, the Aramids business generated net sales of
The Aramids divestiture will not impact DuPont's intended separation of its electronics business (Qnity), which remains on track for a November 1, 2025 spin-off.
Centerview Partners and Goldman Sachs & Co. LLC and are serving as DuPont's financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel. Piper Sandler & Company is serving as financial advisor and Kirkland & Ellis LLP is serving as legal counsel to TJC/Arclin.
About Arclin
Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in
About TJC
TJC, L.P., formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Diversified Industrials, Industrial Technology, Consumer & Healthcare,Logistics & Supply Chain and Technology & Infrastructure. With
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at. Investors can access information included on the Investor Relations section of the website at.
For further information:
DuPont Investors:
Ann Giancristoforo
[email protected]
+1 989-294-5890
Ed Barna
[email protected]
+1 302-596-6050
Media:
Dan Turner
[email protected]
+1 302-299-7628
DuPontTM and all products, unless otherwise noted, denoted with TM, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target, "outlook," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance, including with respect to the potential impact of tariffs and discussion of trade sensitivity and macroeconomic uncertainties. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.
Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the ability of DuPont to effect the Intended Electronics Separation and to meet the conditions related thereto; (ii) the possibility that the Intended Electronics Separation will not be completed within the anticipated time period or at all; (iii) the possibility that the Intended Electronics Separation will not achieve its intended benefits; (iv) the impact of Intended Electronics Separation on DuPont's businesses and the risk that the separation may be more difficult, time-consuming or costly than expected, including the impact on DuPont's resources, systems, procedures and controls, diversion of management's attention and the impact and possible disruption of existing relationships with customers, suppliers, employees and other business counterparties; (v) the possibility of disruption, including disputes, litigation or unanticipated costs, in connection with the Intended Electronics Separation; (vi) the uncertainty of the expected financial performance of DuPont or the separated company following completion of the Intended Electronics Separation; (vii) negative effects of the announcement or pendency of the Intended Electronics Separation on the market price of DuPont's securities and/or on the financial performance of DuPont; (viii) the ability to achieve anticipated capital structures in connection with Intended Electronics Separation, including the future availability of credit and factors that may affect such availability; (ix) the ability to achieve anticipated credit ratings in connection with the Intended Electronics Separation; (x) the ability to achieve anticipated tax treatments in connection with the Intended Electronics Separation and completed and future, if any, divestitures, mergers, acquisitions and other portfolio changes and the impact of changes in relevant tax and other laws; (xi) the ability to timely effect, if at all, the Aramids divestiture to Arclin, a TJC LP company, and the impact of the Aramids divestiture and ownership of a minority interest, estimated to be
View original content to download multimedia:
SOURCE DuPont